Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation

Lignende værker

• Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation
  af: Hermanson, Daniel J., et al.
  Udgivet: (2013)
• (R)-Profens Are Substrate-Selective Inhibitors of Endocannabinoid Oxygenation by COX-2
  af: Duggan, Kelsey C., et al.
  Udgivet: (2011)
• Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation
  af: Bluett, R J, et al.
  Udgivet: (2014)
• Analysis of Endocannabinoids, their Congeners and COX-2 Metabolites
  af: Kingsley, Philip J., et al.
  Udgivet: (2009)
• Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors
  af: Bedse, Gaurav, et al.
  Udgivet: (2018)